Accountability in global health systems: insights from a network analysis of Purdue Pharmaceuticals
Abstract Beginning in 1996, Purdue Pharmaceuticals (Purdue) knowingly mislabeled and mass marketed OxyContin (oxycodone), an opioid painkiller, catalyzing the opioid crisis which has been responsible for more than 600 000 deaths in and beyond North America. This case is an extreme example of how tra...
Saved in:
| Main Authors: | Andrea Bowra, Amaya Perez-Brumer, Lisa Forman, Jillian Clare Kohler |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Globalization and Health |
| Online Access: | https://doi.org/10.1186/s12992-025-01140-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations
by: Jillian Kohler, et al.
Published: (2022-12-01) -
Design and Characterization of the Modified Purdue Subcritical Pile for Nuclear Research Applications
by: Matthew Niichel, et al.
Published: (2025-06-01) -
An Analysis of Selected Data Practices: A Case Study of the Purdue College of Agriculture.
by: Line Pouchard, et al.
Published: (2016-12-01) -
Decolonizing global health: Africa’s pursuit of pharmaceutical sovereignty
by: Moses Mulumba, et al.
Published: (2025-08-01) -
Latin America at the margins? Implications of the geographic and epistemic narrowing of ‘global’ health
by: Amaya Perez-Brumer, et al.
Published: (2024-12-01)